Company reports robust sales of COVID-19 tests and net income per common share of $0.43 Salt Lake City, Utah – August 13, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of...

read more